![Thomas Graney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Graney
Directeur/Membre du Conseil chez
Mogrify Ltd.
Profil
Thomas Graney is currently a Non-Executive Director at Mogrify Ltd. He previously served as the Chief Executive Officer & Director at Oxurion NV from 2020 to 2023, and as an Independent Non-Executive Director at AC Immune SA from 2016 to 2023.
He also held positions as an Independent External Director at Notable Labs Ltd. from 2023 to 2024, Chief Financial Officer & Senior Vice President at Vertex Pharmaceuticals, Inc. from 2017 to 2018, CFO, Senior VP-Finance & Corporate Strategy at Ironwood Pharmaceuticals, Inc. from 2014 to 2017, and Chief Financial Officer & Vice President-Finance at Ethicon, Inc. from 2010 to 2014.
Additionally, he served as the Chief Financial Officer at Tibotec Pharmaceuticals from 2005 to 2008.
Mr. Graney obtained an undergraduate degree from the University of Delaware and an MBA from The Leonard N Stern School of Business.
Postes actifs de Thomas Graney
| Sociétés | Poste | Début |
|---|---|---|
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Develops cellular conversion technology solutions | Directeur/Membre du Conseil | 02/11/2021 |
Anciens postes connus de Thomas Graney
| Sociétés | Poste | Fin |
|---|---|---|
| OXURION NV | Directeur Général | 28/12/2023 |
| AC IMMUNE SA | Directeur/Membre du Conseil | 01/01/2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur Financier/CFO | 13/12/2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/09/2017 |
Formation de Thomas Graney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and devices for surgery | Health Technology |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Tibotec Pharmaceuticals | |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Develops cellular conversion technology solutions | Health Technology |
Choisissez Zonebourse 
